Lan Kang

Lan Kang

Director/Board Member at AVANTOR, INC.

Net worth: 759 907 $ as of 2024-04-29

55 year
Finance
Health Technology
Consumer Services

Profile

Lan Kang is currently the Chairman at Pramerica Fosun Life Insurance Co. Ltd., the Director at Ironshore, Inc., the Independent Director at Avantor, Inc., the Senior Managing Director at Shanghai Kangshiqiao Business Consulting Co. Ltd., and the Managing Director at C Bridge Value Creation Ltd.
Previously, Ms. Kang served as the Chairman of the Board at AmeriTrust Group, Inc., the Vice Chairman of the Board at Fidelidade Companhia de Seguros SA, the Executive Director & Chief Human Resources Officer at Fosun International Ltd., the Non-Executive Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd., the Director at Peak Reinsurance Co., Ltd., and the Non-Executive Director at Everest Medicines Ltd.
Ms. Kang also held positions at Fosun United Health Insurance Co. Ltd., Fosun Pharma Group Co. Ltd., I-MAB Biopharma Co., Ltd., I-Mab, McKinsey & Co., Inc., and Shanghai Fosun High Technology (Group) Co., Ltd.
Ms. Kang started their career as a Project Manager at Nanjing Jiangbei New Area Industrial Investment Group Co. Ltd.
and later worked as a Senior Client Partner at Korn.
Ms. Kang also served as a Senior Advisor at Shanghai Henlius Biotech, Inc. Ms. Kang received a graduate degree from Tulane University (Louisiana), an undergraduate degree from Zhejiang University, and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-08 30,215 ( 0.00% ) 759 907 $ 2024-04-29

Lan Kang active positions

CompaniesPositionStart
AVANTOR, INC. Director/Board Member 2021-04-13
Shanghai Kangshiqiao Business Consulting Co. Ltd. Private Equity Investor 2020-11-30
C Bridge Value Creation Ltd. Chief Executive Officer -
Chairman 2017-08-31
Director/Board Member 2014-12-31
All active positions of Lan Kang

Former positions of Lan Kang

CompaniesPositionEnd
I-MAB Director/Board Member 2024-03-31
EVEREST MEDICINES LIMITED Director/Board Member 2024-01-11
SHANGHAI HENLIUS BIOTECH, INC. Consultant / Advisor 2020-02-29
Chairman 2018-11-30
░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Lan Kang's experience

Training of Lan Kang

Tulane University (Louisiana) Graduate Degree
Zhejiang University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lan Kang's experience

Connections

99

1st degree connections

23

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
FOSUN INTERNATIONAL LIMITED

Finance

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Health Technology

AVANTOR, INC.

Process Industries

SHANGHAI HENLIUS BIOTECH, INC.

Health Technology

EVEREST MEDICINES LIMITED

Health Technology

I-MAB

Health Technology

Private companies14

Finance

Commercial Services

Finance

Finance

Nanjing Jiangbei New Area Industrial Investment Group Co. Ltd.

Finance

Finance

Commercial Services

Finance

Shanghai Kangshiqiao Business Consulting Co. Ltd.

Finance

Health Technology

Health Services

C Bridge Value Creation Ltd.

Fosun Pharma Group Co. Ltd.

Finance

See company connections